according to merrill goozner , there are conflicts of interest on the fda panel which will review the link between ssris and suicide andrew leon is one member whose links to big pharma seem significant , yet fda issued him a waiver so that he can stay on the panel bruce pollock will not vote , but will be on the committee , and goozner documents that he also has significant conflicts of interest even the consumer advocate is reported as having significant conflicts of interest ! in terms of her holding stock in drug companies apparently the fda could not locate a consumer advocate without a significant conflict of interest this is well past strange for the details , check out goozner s post give the highly controversial nature of the topic , one would think that the fda would want the committee to appear as clean as possible the conflicts of interest do not necessarily mean that the fix is in , but at the very least , it makes for very bad pr